Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database.

Seohyun KimSungho BeaSeung-Ah ChoeNam-Kyong ChoiJu Young Shin

Published in: European journal of clinical pharmacology (2024)

In addressing the imperative to comprehend AEFI related to autoimmune disorders following COVID-19 vaccination, our study identified four potential safety signals. Thus, our research underscores the importance of proactive safety monitoring for the identification of the four AEFIs following COVID-19 vaccination, considering the associated advantages.

Keyphrases

coronavirus disease
sars cov
multiple sclerosis
drug induced
climate change
human health
electronic health record
bioinformatics analysis